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Overview 
• What are benzodiazepines? 
• What do we know from previous research 
and what do we want to find out? 
• Approach to meta-synthesis 
• Core themes identified in the literature 
(explanatory framework/model) 
• Recommendations for practice, policy and 
future research 
Background: What are BZDs and 
what is the research problem? 
• Benzodiazepines are widely prescribed to treat 
conditions such as insomnia, anxiety and chronic 
back pain 
• The have limited long-term benefits, and are 
known to have adverse effects and to be 
addictive 
• Consequently NICE guidance recommends that 
they should only be prescribed short-term 
• However, we know that they are used long-term 
– why? 
Previous Research 
• Previous research has detailed variation in 
prescribing practice by: 
– Patient demographics 
– GP attributes 
– Different general practice structures 
• Variation could also be explained by GPs’ 
own experiences and perceptions – an 
area investigated in some qualitative 
studies 
Aim 
• To synthesise findings from qualitative 
studies exploring clinicians’ experiences 
and perceptions of benzodiazepine 
prescribing 
• To build an explanatory model of 
processes underlying benzodiazepine 
prescribing 
Method 
• A meta-synthesis of relevant qualitative 
research 
• Step 1: Identification of relevant studies through 
a systematic review of the literature 
– Developed and applied a search across the following 
databases: MEDLINE, CINAHL, Social Science 
Citation Index, Science Citation Index, PsycINFO, 
Sociological Abstracts and AMED 
– Identified 1110 possible papers for inclusion 
– Removed duplicates and applied inclusion and 
exclusion criteria to narrow this down 
• Studies assessed by two pairs of reviewers and 
needed to: 
– Use both qualitative data and analysis 
– Contain GP or nurse generated data on their 
experiences of prescribing benzodiazepines in 
Western primary care settings (European 
country/USA/ Australia/New Zealand) 
– Have been published between January 1990 and 
August 2011 in a European language 
• Result – 8 papers met the inclusion criteria 
Inclusion/Exclusion Criteria 
• Step 2: Quality Assessment 
– Included papers were assessed by two pairs 
of reviewers using the Critical Appraisal Skills 
Programme checklist (CASP) 
– No studies were excluded from the review on 
the basis of study quality 
• Step 3: Data synthesis 
– We used the ‘thematic synthesis’ approach 
to meta-synthesis: 
 
1. Line-by-line coding of the results sections of 
papers 
2. Creation of descriptive themes 





The included studies were: 
• From 7 different countries 
• Published between 1993 and 2010 
• Based on semi-structured interview data 
(n=7) and focus group data (n=1) 
 
Themes 
• 7 core themes were identified within the data 
and used to produce an explanatory model 
• GPs stated that they are now better 
informed about the risks and side-effects 
BZD use – change from optimistic to 
cautious culture of prescribing 
– GPs increasingly encounter patients who 
would previously have been treated in 
secondary care 
– This theme underpins many of the others (as 
shown later) 
 
1. The changing context of BZD 
prescribing 
2. The Role and Responsibility of the 
GP 
• Some GPs take on responsibility for 
‘correcting’ past prescribing, whilst others 
state that the adverse effects have been 
over-stated and/or blame others for 
initiating prescribing 
• Tension between minimising BZD use and 
wanting to help patients 
• Leads to ambivalent attitudes and 
inconsistent management strategies 
3. The ‘deserving patient’ 
• Need to justify giving or withholding a 
prescription 
• Characteristics such as elderly, female, 
long-term users, multiple diseases, 
psychosocial problems 
• Also need to elicit public sympathy 
• However, rules are not rigidly applied e.g. 
elderly patients/those that GPs empathise 
with or know well 
4. Perceived patient expectation 
• Prescribing was also influenced by the way 
doctors perceived both a patient’s 
expectations, and their motivation and 
ability to cope  
• Often the treatment option chosen is 
based on assumptions about the patient’s 
preferences rather than direct discussion 
5. GP attitudes towards different 
interventions 
• The treatment option GPs chose was 
influenced by their attitudes towards and 
beliefs about different interventions  
– Range of views on the nature of BZDs 
– Knowledge of alternative treatments 
– Perception of alternative treatments 
6. Different challenges faced for managing 
initiation and withdrawal 
• The ‘deserving patient’ characteristics feed into 
both initiation and continuation of prescribing 
• There may be specific barriers to withdrawal e.g. 
fear of loss of patients, previous failure at 
attempting withdrawal, perceived lack of valid 
alternatives (latter is also a reason for initiation) 
7. Ambivalent attitudes towards prescribing 
benzodiazepines leading to inconsistent management 
strategies for prescribing benzodiazepines 
• Combination of the factors described 
previously leads to ambivalent attitudes 
towards BZDs – continuum of prescribing 
• Development of ‘rules’ for prescribing e.g. 
minimal use/short-term use only/patient 
education/specific patient characteristics, 
but these were inconsistently applied 
Findings in Context 
• Previous study of uncomfortable prescribing decisions 
(Bradley, 1992) - combination of factors, rather than one 
single factor which makes it difficult 
 
• Short timescales and uncertainty lead to generalisation – 
Kahneman’s representativeness heuristic 
 
• ‘Deserving patient’ – affect heuristic – replacing hard 
question with easier one 
 
• Greater empathy – more impulsive decisions – prescribe 
 
• Assumptions about patients’ expections (Dyas et al., 
2010) 
Recommendations for practice, policy and 
future research 
Continued 
• Address knowledge deficits through increasing 
education and training for GPs (particularly high 
prescribers) 
• Change attitudes towards, and understanding 
of, alternative types of treatment 
• Long-term increase the availability and 
accessibility of alternatives such as computerised 
cognitive behavioural therapy for insomnia  
• Increase awareness of the impact of empathy 
and perceived patient expectations on decision-
making – direct discussion and reflection 
Thank-you for listening! 
Find out more about our research at: 
www.CaHRU.org.uk  
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